Benaroya Research Institute at Virginia Mason | Clinical Trials Unit

Research site

Site insights

Top conditions

Top treatments


Parent organization

This site is a part of Benaroya Research Institute at Virginia Mason

Data sourced from

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulati...

Colorectal Cancer Stage III
Colorectal Cancer Stage II
Drug: RO7198457 intravenous (IV)
Other: Observational group (no intervention)

The purpose of this study is to assess the safety and efficacy of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in par...

Hepatocellular Carcinoma
Drug: Atezolizumab
Drug: Bevacizumab

The purpose of this study was to compare the overall survival (OS) of participants with locally advanced or metastatic urothelial cancer treated with...

Active, not recruiting
Bladder Cancer
Urothelial Cancer
Drug: Enfortumab Vedotin
Drug: Vinflunine

This is a randomized, parallel group, double-blind Phase 2 study that consists of 2 parts. In Part A the safety of the highest dose-level of frexalim...

Type 1 Diabetes Mellitus
Drug: Placebo
Drug: Insulin

Trial sponsors

Astellas logo
BioNTech logo
Celgene logo
Genentech logo
National Cancer Institute (NCI) logo
National Institutes of Health (NIH) logo
Sanofi logo
Stemline Therapeutics logo
Vanderbilt University Medical Center logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems